Martha B. Pitman,MD Profile
Martha B. Pitman,MD

@marthabpitman

Followers
4K
Following
378
Statuses
2K

Professor of Pathology, Harvard Medical School, Director of Cytopathology, Massachusetts General Hospital

Joined October 2014
Don't wanna be here? Send us removal request.
@marthabpitman
Martha B. Pitman,MD
7 days
@IACytology @IARCWHO Wonderful news! Many people worked long and hard to make this book a reality. Enjoy❤️
1
0
4
@marthabpitman
Martha B. Pitman,MD
1 month
RT @IACytology: Pls RT! Don't miss next Friday's #IACwebinar on Cervical Adenocarcinoma: Cytology, Histology & a Potpourri of Interesting C…
0
11
0
@marthabpitman
Martha B. Pitman,MD
4 months
RT @PapSociety: Take a note of PSC companion society talk happening at #ASC2024! @cytopathology with renowned speakers! including @marthabp
0
7
0
@marthabpitman
Martha B. Pitman,MD
4 months
RT @IACytology: Travel Bursary Grant: Apply now! The #IACFoundation is currently supporting travel bursary grants to IAC members who are cy…
0
8
0
@marthabpitman
Martha B. Pitman,MD
4 months
RT @IACytology: Pls RT! Our #IACcongress is fast approaching. You would love to attend, but don't have the means for this trip? Check out,…
0
11
0
@marthabpitman
Martha B. Pitman,MD
7 months
Apply for a bursary grant to attend the IAC Meeting in Florence via the IAC website- Foundation page (link in photo is not active)
Tweet media one
0
7
18
@marthabpitman
Martha B. Pitman,MD
7 months
@IACytology Apply now via IAC website (link in photo is not active)
Tweet media one
0
1
6
@marthabpitman
Martha B. Pitman,MD
11 months
@Sinchita_Roy @PapSociety @dinamoMD Congrats to all of the awardees!
0
0
1
@marthabpitman
Martha B. Pitman,MD
1 year
Correct diagnosis: Adenoid cystic carcinoma. The patient had a salivary gland primary. Primary pulmonary adenoid cystic carcinomas do occur, so the diagnosis is based on morphology and the "metastatic" comes from history.
0
1
13
@marthabpitman
Martha B. Pitman,MD
1 year
@cytopathology It is going to be great! Hope to see you there❤️
0
0
3
@marthabpitman
Martha B. Pitman,MD
1 year
@cytopathology Get you bling together and be there!
0
0
2
@marthabpitman
Martha B. Pitman,MD
1 year
@TheLabDoc Cancer
2
0
7
@marthabpitman
Martha B. Pitman,MD
1 year
RT @IACytology: Fortify your fluid #cytology! Reinvigorate your respiratory tract! Stimulate your salivary gland FNA! Register for the one-…
0
6
0
@marthabpitman
Martha B. Pitman,MD
1 year
But if the results are unexpected, we give the clinician a heads up before signing out the case.
@SadiaSayeedMD
Sadia Sayeed, MD
1 year
Q4: How has the Cures Act changed your reporting style? Do you hold results until all parts are complete? #JASCchat #ASCejournalchat @JASCJOURNAL @marthabpitman @MikeThrallMD @MlisaZhang @raghupillappa @cytopathology @MHoganMD @Baskotacytopath
1
0
1
@marthabpitman
Martha B. Pitman,MD
1 year
We keep as one specimen but get subspecialty support when needed.
@SadiaSayeedMD
Sadia Sayeed, MD
1 year
Q1: How are multiple part EBUS cases reported at your institution? #JASCchat #ASCejournalchat@JASCJOURNAL @marthabpitman @MikeThrallMD @MlisaZhang @raghupillappa@cytopathology
1
1
7
@marthabpitman
Martha B. Pitman,MD
1 year
RT @CancerCytopath: "The approach that cytology has taken to embrace a more explicit risk-based method to classifying difficult biopsy spec…
0
14
0
@marthabpitman
Martha B. Pitman,MD
1 year
RT @SadiaSayeedMD: Please join me tonight at 9 pm ET for the ejournal Twitter chat! @cytopathology @JASCJOURNAL @marthabpitman @MHoganMD @r
0
5
0
@marthabpitman
Martha B. Pitman,MD
2 years
@sza_jhcyto A true legend.
0
0
4